Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy

NCT04703686

Conditions
Diffuse Large B-cell Lymphoma Refractory, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • CHU Amiens Picardie Site sud Amiens, France
  • CHU de Clermont Ferrand Clermont-Ferrand, France
  • Hopital Henri Mondor Créteil, France
  • CHU de Dijon - Hôpital le Bocage Dijon, France
View all 19 locations
View Trial Details
Completed

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

NCT02213913

Conditions
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +104 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
View Trial Details
Completed

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

NCT04282018

Conditions
Advanced Solid Tumor, Chronic Disease, Chronic Lymphocytic Leukemia, +27 more
Locations
  • Blacktown Cancer and Haematology Centre Blacktown, New South Wales, Australia
  • Saint Vincents Hospital Sydney Darlinghurst, New South Wales, Australia
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Gallipoli Medical Research Foundation Greenslopes, Queensland, Australia
View all 24 locations
View Trial Details
Completed

A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)

NCT04849416

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Wannan Medical College Yijishan Hospital Wuhu, Anhui, China
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 22 locations
View Trial Details
Completed

Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

NCT04116437

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +29 more
Locations
  • Rocky Mountain Cancer Centers (Williams) Usor Aurora, Colorado, United States
  • Christiana Care Newark, Delaware, United States
  • Scri Florida Cancer Specialists South Fort Myers, Florida, United States
  • St Century Oncology Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Completed

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

NCT03740529

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +35 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • Scripps Coastal Medical Center San Diego, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
View all 56 locations
View Trial Details
Completed

A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

NCT05665530

Conditions
Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Bone Marrow Diseases, +41 more
Locations
  • City of Hope Duarte, California, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View all 24 locations
View Trial Details

Related conditions